lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐ ZNF395 Axis
Cancer Science · 2026-01 · 117 (1) · 145-155
DOI: 10.1111/cas.70236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 30.10.2025. Verfasst von Yawen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: MicroRNAs, Liver Neoplasms, Cancer-Associated Fibroblasts, RNA, Long Noncoding. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Excellent Youth Talent Training Program of Affiliated Hospital of Zunyi Medical University, Science and Technology Program of Zunyi City.
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs) play important roles in the progression of hepatocarcinoma, while the mechanism underlying the pro‐invasive transformation of normal fibroblasts (NFs) to CAFs remains poorly defined. lncDILC is a long non‐coding RNA previously identified to be downregulated in liver cancer stem cells. Here, we found that lncDILC was also significantly downregulated in liver cancer CAFs compared with NFs. Knockdown of lncDILC in NFs facilitated their conversion into CAFs, and enhanced the ability to promote the migration and invasion of liver cancer cells. Conversely, overexpression of lncDILC in CAFs ameliorated their invasive characteristics, and suppressed cancer cell metastasis. Moreover, we found miR‐6071 acted as a target of lncDILC, and functioned as a transcriptive suppressor of zinc finger protein 395 (ZNF395), which exhibited an inhibitory effect on the pro‐invasive conversion of fibroblasts. Overexpression of ZNF395 reversed the pro‐invasive effects induced by lncDILC knockdown. These results elucidate a pathway of lncDILC‐miR‐6071‐ZNF395 that suppresses the NF‐CAF conversion, suggesting new therapeutic targets for the strategies for the treatment of liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Yawen Li, Xuemei Liu
Förderung
- National Natural Science Foundation of China
- Excellent Youth Talent Training Program of Affiliated Hospital of Zunyi Medical University
- Science and Technology Program of Zunyi City
- Guizhou Provincial Science and Technology Program
Zitieren
APA
Li, Y., Liu, J., Tai, S., Tong, D., Wang, B., Lu, D., Shi, G., & Liu, X. (2026). lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐ ZNF395 Axis. Cancer Science, 117(1), 145-155. https://doi.org/10.1111/cas.70236
Vancouver
Li Y, Liu J, Tai S, Tong D, Wang B, Lu D, et al. lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐ ZNF395 Axis. Cancer Science. 2026;117(1):145-155. doi:10.1111/cas.70236
BibTeX
@article{Li2026,
author = {Li, Yawen and Liu, Jilong and Tai, Shentao and Tong, Dandan and Wang, Bifeng and Lu, Dingbing and Shi, Guoqing and Liu, Xuemei},
title = {lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐ ZNF395 Axis},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {1},
pages = {145--155},
doi = {10.1111/cas.70236}
}
EUVIMED